ABT vs DXCM
Abbott Laboratories vs Dexcom — AI-powered side-by-side comparison
| Metric | ABT | DXCM |
|---|---|---|
| AI Score | 55 | 58 |
| Price | $100.58 | $71.44 |
| P/E Ratio | 27.69× | 31.15× |
| ROE | 0.1% | 0.3% |
| Revenue Growth YoY | — | — |
| Gross Margin | 0.6% | 0.6% |
| Debt / Equity | 0.65× | 0.47× |
| Dividend Yield | 0.0% | 0.0% |
| RSI (14) | 64.7 | 52.3 |
| Beta | 0.607 | 1.453 |
| Expected Upside | +6.9% | +1.6% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ABT Full Analysis
DXCM Full Analysis